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Abstract
Background: A pancreatic fistula (PF) is a major contributor to morbidity and mortality after a
pancreaticoduodenectomy (PD). There remains debate as to whether re-establishing pancreaticoenteric
continuity by a pancreatico-gastrostomy (PG) can decrease the risk of a PF and complications compared
with a pancreatico-jejunostomy (PJ). The outcomes of patients undergoing these reconstructions after a
PD were compared.
Method: Patients undergoing a PD between 1999 and 2011 were selected from a prospective database
and having undergone either a PG or PJ reconstruction. A propensity-score adjusted multivariate logistic
regression was performed to identify the effect of surgical technique on outcomes of PF, delayed gastric
emptying (DGE) and total complications.
Results: Twenty-three out of 103 and 20 out of 103 (P = 0.49) patients had PF and 74 out of 103 and 55
out of 103 patients had all-grades DGE in the PG and PJ groups, respectively (P = 0.02). The groups did
not differ with regards to Clavien–Dindo grade of complications (P = 0.29) but did differ with regards to the
Comprehensive Complication Index (CCI) (38.4 versus 31.4 for PG versus PG, respectively, P = 0.02.)
Propensity-score adjusted multivariate analysis showed no effect of PG on PF (P = 0.89), DGE grades B/C
(P = 0.9) or CCI (P = 0.41). There remained an effect on all-grades of DGE (P = 0.012.)
Discussion: Patients undergoing PG reconstruction had a similar rate of PF as those undergoing a PJ
after a PD.
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Introduction
Pancreatic cancer is now the 10th most common cancer and the 4th
cause of cancer death in both men and women in North America.1
Surgical resection provides the only opportunity for a cure, but
only 10% of patients with pancreatic adenocarcinoma are surgical
candidates at the time of diagnosis.2 In addition to the complica-
tions of abdominal surgery, pancreatic fistulae (PF) weigh heavily
on the morbidity and mortality burden incurred by patients after
a pancreaticoduodenectomy (PD).3 The traditional approach uses
pancreatico-jejunostomy (PJ) and many surgeons have proposed
variations thereof, such as dunking, Peng’s binding and the
Blumgart approach.4,5 However, pancreatico-gastrostomies (PG)
have gained favour with some surgeons, as meta-analysis of retro-
spective series have suggested superiority with regards to PF.6
However these studies are small, heterogeneous and did not adjust
for known risk factors of PF.7 Most randomized trials to date have
failed to convincingly support the meta-analysis findings,8 thus
there remains debate regarding the best approach. Ongoing
randomized trials are attempting to answer the question.9
Although conventional randomized designs are generally less
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prone to bias, the internal and external validity of randomized
trials examining this particular issue may be compromised. The
main issue is the randomization process which forces a surgeon to
perform both repairs such that there may not be true equipoise in
that there is a belief by the surgeon that one option is superior. An
informal survey at the 2014 American Association for Hepato-
Pancreao-Biliary Surgeons meeting revealed that, respectively, 4%
and 2% of surgeons stated they ‘always’ or ‘frequently’ use PG,
with 62% stating they never use PG and 23% only using it occa-
sionally (conference proceedings, unpublished data). Deveraux
and Bandahri have suggested an expertise-based design where
patients are randomized to a surgeon performing their ‘best’
operation.10
At our institution, referred patients are assigned non-
purposefully to surgeons each having a strong personal preference
for either PG or PJ, and each operating well beyond the procedural
learning curve for their ‘favoured’ repair – this unique setting is
not unlike that expertise-based trial, wherein each procedure is
performed expertly and proficiently, with other aspects of patient
care (pre-operative workup and post-operative management)
being identical. Our goal was to examine themorbidity experience
of PG or PJ after a PD at our institution and to use a propensity-
score to adjust for differences between the groups and mitigate
confounding.
Patients and methods
Setting, patient selection and group allocation
Patients having undergone a PD from 1999 to 2011 for any indi-
cation at the McGill University Health Centers (MUHC) were
identified from a prospectively collected database and operating
room records. Patients operated by surgeons with a surgical
volume of less than five were excluded. Medical records were
reviewed to supplement the database after obtaining approval
from the hospital ethics review board. The MUHC is a tertiary
care centre where three experienced surgeons performing a PD
have a high personal preference for PJ or PG reconstruction, and
where patients are assigned to surgeons based on each surgeon’s
waitlist availabilities. The surgeons are fellowship-trained
hepatobiliary surgeons with an equivalent experience and more
than 150 pancreatectomies documented before 1999. Surgeons
did not alter their preferred technique based on pancreatic texture
or duct diameter. The hospital, in the city of Montreal, is one of
three provincial referral centres for hepato-pancreatico-biliary
surgical oncology in a state with a single-payer publically funded
system.
Peri- and post-operative management
Patients were assessed at the same pre-operative clinic and
managed on the same surgical ward by a common team of resi-
dents and fellows. All patients received antibiotic and deep venous
thrombosis prophylaxis at induction of anaesthesia. Prophylactic
octreotide was not used routinely. All patients received two (2)
intra-abdominal closed-suction drains placed in proximity to the
pancreatico-enteric and choledocho-enteric anastomosis. All
patients received a nasogastric (NG) tube. Jejunal feeding tubes
were only exceptionally used. PJ consisted of duct-to-mucosa,
end-to-side anastomosis with a pancreatic duct stent and PG con-
sisted of a ‘dunking’ single layer posterior-wall gastrostomy.11
Routine testing of drain amylase was done in all cases but timing
of drain removal was left to the treating team.
Outcomes definition
The ISGPF definition of a PF and both the ISGPF12 and the
Strasberg and Linehan13 grading systems for PF severity were used.
Delayed gastric emptying was assessed using the ISGPS defini-
tion.14 Total 90-day complications were assessed using the
Clavien–Dindo classification15 as well as the Comprehensive
Complication Index (CCI).16 This tool is free to use and can be
calculated online (http://www.assessurgery.com). Patients were
considered ever-smoker if they were smoking at the time of
surgery or had been smokers previously. Intra-abdominal collec-
tion was defined as the radiological or re-operative finding of fluid
collections in the surgical field – no size or volume limitations
were imposed.Wound infections were defined as any wound with
cellulitis, purulent drainage, and any incision requiring opening
and packing or vac therapy.
Statistical analysis
Statistical analysis was performed using the Stata software, version
12.1 (StataCorp, TX, USA; http://www.stata.com). T-tests and
anova were employed to compare the means of normally distrib-
uted continuous data, Wilcoxon’s Rank-Sum test for non-
normally distributed continuous data, and χ2 test for categorical
data. Propensity factors were identified ad hoc as variables associ-
ated with assignment to PG at univariate logistic regression with a
P < 0.15. No propensity factors were pushed into the model a
priori. The propensity score was obtained using a predictive func-
tion after a multivariate logistic regression with surgical technique
as the outcome and the propensity factors as covariates. No quad-
ratic functions or interaction terms were used to enhance the
model. The propensity score was used as a co-variate in univariate
and multivariate logistic regressions to determine the relationship
between PG and surgical outcomes.
Results
Baseline characteristics and construction of the
propensity score
One-hundred and three PG and 103 PJ were identified as having
been performed by three surgeons. Table 1 summarizes baseline
patient demographic, pre-operative and pathological characteris-
tics. Both groups were relatively similar with regards to measured
variables except for smoking, dyslipidemia, chronic obstructive
pulmonary disease and diagnosis of intraductal papillary
mucinous neoplasm (IPMN) or cholangiocarcinoma. These
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factors differed sufficiently between the two groups to be consid-
ered propensity factors and were used to construct the propensity
score.
PF
Morbidity of the two groups is summarized in Table 2. Peri-
operative transfusion and diagnosis of cholangiocarcinoma or
adenocarcinoma had a statistically significant association with PF
at univariate logistic regression and were included as risk factors
in the multivariate analysis. A body mass index (BMI) of more
than 35, although not statistically significant as a PF risk factor,
was included in the multivariate analysis owing to a well-
documented relationship between obesity, pancreatic texture and
PF in the literature. Soft pancreatic texture [odds ratio (OR) = 21,
P = 0.006] and pancreatic duct diameter [OR = 0.4, P = 0.027]
were also statistically significant risk factors, but we could not be
included in the multivariate analysis owing to missing data –
including them as covariates radically decreased the sample size.
Table 3a shows the results of univariate, propensity-score adjusted
and multivariate propensity-score adjusted logistic regression
examining the relationship between the reconstructive option and
PF. The OR for PG was 1.19 (0.6–2.3) (P = 0.6) at univariate
analysis, 0.87 (0.4–1.8) (P = 0.72) at propensity-score adjusted
analysis and 0.97 (0.4–2.2) (P = 0.9) at propensity-score adjusted
multivariate analysis.
DGE
At univariate, multivariate and propensity-score adjusted multi-
variate analysis, there was no effect of surgical reconstructive
option on DGE grades B/C (Table 3.) There was a statistically
significant difference in all-grade DGE (79/103 versus 55/103 for
PG versus PJ respectively, P = 0.02). This remained significant
at propensity-score adjusted multivariate regression (OR = 2.4,
P = 0.012).
Other outcomes
The median length of stay was not statistically significant between
the two groups (18 and 14 days in the PG and PJ groups, respec-
tively, P = 0.20). There was no difference in all-cause 90-day mor-
tality between the two groups (9/103 and 5/103, P = 0.27.) Six out
of 14 deaths had a PH, 3 out of 14 had myocardial infarcts or
cardiac arrest, 2 out of 14 complications of intra-abdominal sepsis
not related to a PF, 2 out of 14 complications of angiographic
interventions for bleeding and 1 out of 14 had multiorgan failure
after anastomotic bleed causing multi-organ failure. The median
CCI differed by 7 points between the two groups (P = 0.027) but
this difference did not remain significant after adjusting for pro-
pensity score (P = 0.4.) The distribution of morbidity as measured
by the Clavien–Dindo classification did not differ between the two
groups (P = 0.85). CCI did not differ by propensity score
(P = 0.4).
Table 1 Patient characteristics in the pancreatico-gastrostomy (PG)
and pancreatico-jejunostomy (PJ) groups
Variable PG PJ P
Age (median and range) 66 (21–88) 66 (23–82) 0.95
Gender
Men 55 (53.4) 46 (44.7)
Women 48 (46.6) 57 (45.3) 0.78
BMI
<25 44 43
25–30 28 27
30–35 7 7
35–40 2 2
>40 1 1 1.0
Ever-smoker 19 33 0.027
Hypertension 34 36 0.89
Dyslypidemia 20 12 0.096
Coronary artery disease 7 13 0.179
Diabetes 19 21 0.81
COPD 10 4 0.083
Peripheral vascular disease 3 4 0.73
ASA >3 48 38 0.106
Jaundice 49 51 0.76
Biliary drainage 40 38 0.8
Cholangitis 10 8 0.637
Weight loss >10% 19 15 0.45
Neoadjuvant chemotherapy 9 5 0.26
Neoadjuvant radiation 2 1 0.5
Tumour size (median, range) 3 (0.2–8.5) 3 (0.1–13) 0.66
T3 59 52 0.55
R1 resection 19 20 0.97
Portal vein resection 7 10 0.46
Lymph nodes (median,
range)
10 (0–38) 9 (1–33) 0.9
Pathology
Adenocarcinoma 46 43 0.7
Cholangiocarcinoma 10 2 0.018
Ampullary carcinoma 8 12 0.321
IPMN 11 3 0.029
Neuroendocrine 7 10 0.421
Duodenal 1 0 0.90
Non-malignant 8 9 0.80
Unknown 4 6 0.75
Others 8 18
BMI, body mass index; COPD, chronic obstructive pulmonary disease;
ASA, American Society of Anesthesiologists; IPMN, intraductal papillary
mucinous neoplasm.
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Discussion
The proportion of patients developing PF in the current series
(20.9%) is similar to that observed in other retrospective studies
that use the ISGPF classification.We did not identify a significant
effect of pancreatico-enteric reconstructive option on the odds of
a PF even after adjusting for propensity score. There was more
overall DGE with PG both at univariate and multivariate
propensity-score adjusted analysis, but there was no increase in
DGE of grades B/C and no impact on length of stay, Clavien–
Dindo or CCI. The mortality rates in our series did not differ
between the two groups. A significant proportion of deaths were
related to PF, consistent with other published series.17 The CCI
and Clavien–Dindo grade of complications did not differ between
the two groups.
The CCI is a recently published tool that measures the weighted
cumulative impact of post-operative complications and adverse
events on a continuous scale;16 as such it is more sensitive than
existing morbidity measures and better reflects the global mor-
bidity experience of the patients. This is the first time the CCI has
been used as a measure of morbidity aside from its validating
publication.16 The magnitude of the difference in CCI at
univariate analysis is therefore difficult to interpret conclusively;
the 7-point difference in CCI between the groups at univariate
analysis is probably attributable to the increased delayed gastric
emptying and slight increase in UTI requiring antibiotic treat-
ment in the PG group. This finding highlights the sensitivity of the
CCI as a measure of the total morbidity experience as compared
with traditional measures such as the Clavien–Dindo.
The belief that PG is protective of PF was supported by a large
number of observational trials; however, a meta-analysis byWente
et al. showed them to be clinically heterogeneous, lacking adjust-
ment for known confounders and at high risk of bias;7 moreover
a strong publication bias in favour of PG was demonstrated.More
recently published meta-analyses of randomized trials have not
conclusively demonstrated PG’s protective effect. The meta-
analysis by Ma et al. of four randomized trials used a random-
effects model and found more intra-abdominal collections with
PJ (OR = 0.46, 95% CI 0.26–0.79, P = 0.005) but no difference in
total morbidity, mortality, PF or DGE. Using the same four
randomized trials and a less conservative fixed-effects model, a
meta-analysis by Shen et al. found an increase in intra-abdominal
complications, but no difference in total complications.8 It
remains unclear if particular subgroups, such as those with
smaller pancreatic ducts, or a soft fatty pancreas, stand to gain
from one technique compared with the other.
Our institution’s setup provides a unique opportunity to study
the outcomes between the two groups. This can contribute to the
literature through the quasi-experimental process of patient allo-
cation as well as the expertise-based nature of the interventions
being compared; this mitigates the confoundedness that had been
the main criticism of previously published retrospective and
observational series showing superiority of PG.Moreover, referral
Table 2 Pancreatic fistula, delayed gastric emptying, morbidity and
mortality in patients undergoing pancreatico-gastrostomy (PG) and
pancreatico-jejunostomy (PJ) after a pancreaticoduodenectomy
Complication PG PJ P
PF 23 20 0.45
ISGBP – grade A 0 1
ISGPF – grade B 8 6
ISGPF – grade C 15 13 0.67
PF – Strasberg & Linehan
Grade I 0 1
Grade II 8 4
Grade IIIA 6 8
Grade IIIB 2 1
Grade IV 2 2
Grade IVA 2 1
Grade V 3 3 0.85
Death 9 5 0.27
Delayed gastric emptying 74/103 55/103 0.02
No DGE 29 48
DGE Grade A 46 37
DGE Grade B/C 28 18 0.6
ICU readmissions 12 16 0.415
TPN 41 40 0.89
Antibiotic therapy 76 58 0.011
CT/US procedure 36 28 0.23
Reoperation 8 13 0.25
Discharged with JP 12 9 0.45
Pulmonary complication 14 13 0.79
Thromboembolic
complication
12 6 0.12
Intra-abdominal collection 28 26 0.64
Bleeding 17 12 0.28
Wound Infection 21 24 0.69
UTI 23 9 0.004
LOS (median) 18 14 0.20
Complications 69/103 62/103
Clavien-Dindo I 3 8
Clavien-Dindo II 28 20
Clavien-Dindo IIIA 13 15
Clavien-Dindo IIIIB 5 1
Clavien-Dindo IV 5 5
Clavien-Dindo IVA 6 8
Clavien-Dindo V 9 5 0.285
CCI 38.4 31.4 0.02
PF, pancreatic fistula; DGE, delayed gastric emptying; ICU, intensive care
unit; TPN, total parenteral nutrition; CT/US, computed tomography/
ultrasound; UIT, urinary tract infection; LOS, length of stay.
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bias is at least partially adjusted for by the propensity score. This
might explain why our results are more consistent with the con-
clusions drawn from most of the randomized studies rather than
the observational series comparing PG and PJ.
We chose to adjust for the propensity score instead of matching
upon it. Similar conclusions are reached when we matched upon
propensity score; however, this approach resulted in a decrease in
our sample size owing to unmatched individuals. Using the pro-
pensity score as a co-variate in multivariate adjustment is as valid
as its use to match individuals;18,19 moreover, matching in an
observational dataset is not without its caveat as it can be a source
of bias itself.
In addition to the quasi-experimental setting, the presence of a
strong surgeon preference for PJ or PGmakes the study akin to an
expertise-based trial, with each technique performed well beyond
the learning curve of surgeons. A notable strength of our study’s
design lies in its comparison of two techniques performed by
expert surgeons well beyond their procedural learning curves.
Effect measures from expertise-based comparisons can therefore
more accurately reflect effects seen in clinical settings than trials
where procedures are compared at different levels of proficiency. 10
The possibility of residual confounding remains a concern
given our inability to adjust for pancreatic duct diameter and
pancreatic texture; however, our adjustment for BMI and pathol-
ogy could have at least partially adjusted for these confounders.
We were unable to perform subgroup analysis to identify whether
PG hadmore benefit in a particular patient subpopulation, but we
can postulate that outcomes are similar in the subset of patients
with a soft pancreatic texture or a small duct.
With no dramatic differences in surgical outcomes at our site,
this study would suggest that pancreatic surgeons should continue
using the reconstructive technique they are most familiar with and
ones that have yielded institutional outcomes similar to those in
published series.
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